Effect of calcium dobesilate on peritoneal equilibration test in peritoneal dialysis patients

Zhang Xue; Wu Wei; Gao Bo; Zheng Jian-nan; Yao Li; Zhu Xin-wang

doi:10.3969/j.issn.1671-2390.2025.03.009

Journal of Clinical Nephrology > 2025 > 25(3): 237-241. > DOI: 10.3969/j.issn.1671-2390.2025.03.009

Zhang Xue, Wu Wei, Gao Bo, Zheng Jian-nan, Yao Li, Zhu Xin-wang. Effect of calcium dobesilate on peritoneal equilibration test in peritoneal dialysis patients[J]. Journal of Clinical Nephrology, 2025, 25(3): 237-241. DOI: 10.3969/j.issn.1671-2390.2025.03.009

Citation:

PDF (567 KB)

Effect of calcium dobesilate on peritoneal equilibration test in peritoneal dialysis patients

1. Department of Nephrology and Peritoneal Dialysis Center, the First Hospital of China Medical University, Shenyang 110001, China;
2. Department of Laboratory Medicine, the First Hospital of China Medical University, Shenyang 110001, China

More Information

Received Date: July 22, 2024

Graphical Abstract

Abstract

- Peritoneal dialysis,
- Peritoneal equilibration test,
- Calcium dobesilate

FullText(HTML)

References (22)

References

[1]	Teitelbaum I. Peritoneal dialysis[J]. N Engl J Med, 2021, 385(19): 1786-1795. DOI: 10.1056/nejmra2100152.
[2]	Ngamvichchukorn T, Ruengorn C, Noppakun K, et al. Association between pretransplant dialysis modality and kidney transplant outcomes: a systematic review and meta-analysis[J]. JAMA Netw Open, 2022, 5(10): e2237580. DOI: 10.1001/jamanetworkopen.2022.37580.
[3]	Chuasuwan A, Pooripussarakul S, Thakkinstian A, et al. Comparisons of quality of life between patients underwent peritoneal dialysis and hemodialysis: a systematic review and meta-analysis[J]. Health Qual Life Outcomes, 2020, 18(1): 191. DOI: 10.1186/s12955-020-01449-2.
[4]	Mehrotra R, Ravel V, Streja E, et al. Peritoneal equilibration test and patient outcomes[J]. Clin J Am Soc Nephrol, 2015, 10(11): 1990-2001. DOI: 10.2215/CJN.03470315.
[5]	王晓培, 马莹, 吕晶, 等. 腹膜透析患者起始透析剂量对生存率的影响[J]. 临床肾脏病杂志, 2021, 21(11): 904-910. DOI: 10.3969/j.issn.1671-2390.2021.11.004. Wang XP, Ma Y, Lyu J, et al. Effect of initial dialysis dose on survival in peritoneal dialysis patients[J]. J Clin Nephrol, 2021, 21(11): 904-910.DOI: 10.3969/j.issn.1671-2390.2021.11.004.
[6]	Galach M, Antosiewicz S, Baczynski D, et al. Sequential peritoneal equilibration test: a new method for assessment and modelling of peritoneal transport[J]. Nephrol Dial Transplant, 2013, 28(2): 447-454. DOI: 10.1093/ndt/gfs592.
[7]	Zhang XY, Liu W, Wu SS, et al. Calcium dobesilate for diabetic retinopathy: a systematic review and meta-analysis[J]. Sci China Life Sci, 2015, 58(1): 101-107. DOI: 10.1007/s11427-014-4792-1.
[8]	Xie ZJ, Wei LJ, Chen JY, et al. Calcium dobesilate alleviates renal dysfunction and inflammation by targeting nuclear factor kappa B(NF-κB) signaling in sepsis-associated acute kidney injury[J]. Bioengineered,2022,13(2):2816-2826.DOI: 10.1080/21655979.2021.2024394.
[9]	Zhang TJ, Guo XZ, Hou LA, et al. Effects of calcium dobesilate (CaD) interference on serum creatinine measurements: a national External Quality Assessment(EQA)-based educational survey of drug-laboratory test interactions[J]. Clin Chem Lab Med, 2020, 59(1): 139-145. DOI: 10.1515/cclm-2020-0424.
[10]	陈香美. 腹膜透析标准操作规程[M]. 2010年版. 北京: 人民军医出版社, 2010: 118-120. Chen XM. Standard operating procedures for peritoneal dialysis[M]. 2010 Edition. Beijing: People's Military Medical Press, 2010: 118-120.
[11]	Guo XZ, Hou LA, Cheng XQ, et al. Strong negative interference by calcium dobesilate in sarcosine oxidase assays for serum creatinine involving the trinder reaction[J]. Medicine (Baltimore),2015,94(23):e905.DOI:10.1097/MD. 000000000000 0905.
[12]	Scott Brimble K, Walker M, Margetts PJ, et al. Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis[J]. J Am Soc Nephrol, 2006, 17(9): 2591-2598. DOI: 10.1681/ASN.2006030194.
[13]	Morelle J, Lambie M, Öberg CM, et al. The peritoneal membrane and its role in peritoneal dialysis[J]. Clin J Am Soc Nephrol,2024,19(2):244-253.DOI:10.2215/CJN.0000000000 000282.
[14]	周润哲, 杨相杰, 孟雨晴, 等. 腹膜透析患者液体状态与肺动脉高压的相关性[J]. 临床肾脏病杂志, 2023, 23(7): 529-535. DOI: 10.3969/j.issn.1671-2390.2023.07.001. Zhou RZ, Yang XJ, Meng YQ, et al. Association between fluid status and pulmonary hypertension in peritoneal dialysis patients[J]. J Clin Nephrol,2023,23(7): 529-535. DOI: 10.3969/j.issn.1671-2390.2023.07.001.
[15]	La Milia V, Cabiddu G, Virga G, et al. Peritoneal equilibration test reference values using a 3.86% glucose solution during the first year of peritoneal dialysis: results of a multicenter study of a large patient population[J]. Perit Dial Int, 2017, 37(6): 633-638. DOI: 10.3747/pdi.2017.00004.
[16]	Paniagua R, Amato D, Correa-Rotter R, et al. Correlation between peritoneal equilibration test and dialysis adequacy and transport test, for peritoneal transport type characterization. Mexican Nephrology Collaborative Study Group[J]. Perit Dial Int, 2000, 20(1): 53-59. DOI: 10.1177/089686080002000110.
[17]	刘晓城, 吕永曼, 金晓冰, 等. 羟苯磺酸钙治疗慢性肾功能不全的临床观察[J]. 中华医学杂志, 2004, 84(22): 1892-1893. DOI: 10.3760/j: issn: 0376-2491.2004.22.013. Liu XC, Lyu YM, Jin XB, et al. The clinical observation of calcium dobesilate in the treatment of chronic renal insufficiency[J]. Natl Med J China, 2004, 84(22): 1892-1893. DOI: 10.3760/j: issn: 0376-2491.2004.22.013.
[18]	潘练华, 麦爱芬, 吕婉娴, 等. 羟苯磺酸钙对肌酐检测的干扰效应评价[J]. 国际检验医学杂志, 2021, 42(19): 2400-2402, 2406. DOI: 10.3969/j.issn.1673-4130.2021.19.022. Pan LH, Mai AF, Lyu WX, et al. Evaluation of dose effect of creatinine detection reagents on calcium dobesilate interference[J]. Int J Lab Med, 2021, 42(19): 2400-2402, 2406. DOI: 10.3969/j.issn.1673-4130.2021.19.022.
[19]	余久如, 潘桂红, 鞠萍. 羟苯磺酸钙对肌氨酸氧化酶法检测肌酐的干扰[J]. 中华检验医学杂志, 2013, 36(2): 161-164. DOI: 10.3760/cma.j.issn.1009-9158.2013.02.015. Yu JR, Pan GH, Ju P. The effect of calcium dobesilate on creatinine measurement by sarcosine oxidase assay[J]. Chin J Lab Med, 2013, 36(2): 161-164. DOI: 10.3760/cma.j.issn.1009-9158.2013.02.015.
[20]	石凌波, 林龙顺. 常见肌酐测定方法中存在的干扰[J]. 中华检验医学杂志, 2001, 24(2): 102-104. DOI: 10.3760/j: issn: 1009-9158.2001.02.012. Shi LB, Lin LS. The interference of common methods in determination creatinine[J]. Chin J Lab Med, 2001, 24(2): 102-104. DOI: 10.3760/j: issn: 1009-9158.2001.02.012.
[21]	余久如, 卢锦莲, 廖建红, 等. 高效液相色谱法检测慢性肾功能不全患者羟苯磺酸钙稳态血药浓度与eGFR及肌酐干扰值相关性分析[J]. 现代检验医学杂志, 2019, 34(4): 62-66. DOI: 10.3969/j.issn.1671-7414.2019.04.015. Yu JR, Lu JL, Liao JH, et al. Determination of the steady-state plasma concentration of calcium dobesilate in patients with chronic renal insufficiency by HPLC and its correlation with eGFR and creatinine interference[J]. J Mod Lab Med, 2019, 34(4): 62-66. DOI: 10.3969/j.issn.1671-7414.2019.04.015.
[22]	国秀芝, 张江涛, 侯立安, 等. 羟苯磺酸钙对尿酸酶-过氧化物酶偶联法尿酸检测的干扰研究[J]. 中华检验医学杂志, 2015, 38(9): 600-604. DOI: 10.3760/cma.j.issn.1009-9158.2015.09.008. Guo XZ, Zhang JT, Hou LA, et al. Negative interference by calcium dobesilate in uricase-peroxidase coupled assays of serum uric acid[J]. Chin J Lab Med, 2015, 38(9): 600-604. DOI: 10.3760/cma.j.issn.1009-9158.2015.09.008.

Cited By

Get Citation

PDF

XML

Article views (6) PDF downloads (1)

Turn off MathJax

Article Contents

References

Effect of calcium dobesilate on peritoneal equilibration test in peritoneal dialysis patients

References

Catalog

Export File

Citation

Format

Content